Related Experiment Video
Updated: Jun 6, 2025

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Buschke-Löwenstein Tumor (BLT): Successful Treatment of Human Papillomavirus (HPV)-Associated Squamous Cell Carcinoma
Stanko J Baćo1, Milos Mitric1, Jovica Mišić2
1General Surgery, Public Health Institution Hospital "Dr Mladen Stojanović", Prijedor, BIH.
Abstract:
The giant condyloma acuminatum, known as the Buschke-Löwenstein tumor (BLT), is an uncommon, slow-growing, cauliflower-like tumor located in the anogenital region. It has a high recurrence rate, is sexually transmitted, and is often linked with immunosuppression. This tumor is commonly associated with human papillomavirus (HPV) infection, making HPV one of the most prevalent sexually transmitted infections affecting the perineal and genital regions. Treatment options primarily involve a combination of surgical excision and adjuvant chemotherapy. In this report, we present the case of a 63-year-old heterosexual, HIV-negative female patient whose locally advanced disease severely impacted her quality of life due to multiple bilateral perianal fistulas and the development of squamous cell carcinoma. The patient also struggled with chronic anemia resulting from recurrent hemorrhages. She underwent a Miles procedure, consisting of an extralevator abdominoperineal excision with terminal colostomy. Following adjuvant chemotherapy, she achieved complete wound healing by secondary intention, with no complications or signs of wart recurrence. This report highlights that surgical resection, complemented by adjuvant therapy, can lead to excellent outcomes even in advanced cases with local progression, regional spread, and malignant transformation, without requiring additional reconstructive surgery or skin grafting, thus facilitating recovery.
More Related Videos
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...